HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gershon Golomb Selected Research

tyrphostin AGL-2043

2/2005Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries.
10/2004Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gershon Golomb Research Topics

Disease

8Neointima
08/2018 - 08/2002
7Hyperplasia
06/2010 - 07/2002
6Neoplasms (Cancer)
11/2019 - 04/2009
6Pathologic Constriction (Stenosis)
11/2011 - 12/2003
5Carcinoma (Carcinomatosis)
11/2019 - 04/2010
4Breast Neoplasms (Breast Cancer)
03/2019 - 04/2010
4Inflammation (Inflammations)
08/2018 - 10/2004
2Infections
03/2022 - 01/2022
2Vascular System Injuries
08/2018 - 02/2007
2Thrombosis (Thrombus)
07/2012 - 11/2011
2Neoplasm Metastasis (Metastasis)
06/2012 - 04/2010
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Liver Failure
01/2022
1Persistent Infection
01/2022
1Liver Diseases (Liver Disease)
01/2022
1Myocardial Infarction
08/2018
1Edema (Dropsy)
10/2017
1Coronary Restenosis
07/2012
1Osteolysis
06/2012
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2011
1Vascular Remodeling
08/2002
1Bone Resorption
02/2002
1Carcinosarcoma
02/2002
1Bone Neoplasms (Bone Cancer)
02/2002

Drug/Important Bio-Agent (IBA)

7Liposomes (Liposome)IBA
11/2019 - 08/2007
5OsteopontinIBA
03/2019 - 04/2010
5Diphosphonates (Bisphosphonates)IBA
08/2018 - 12/2003
5Alendronate (Alendronate Sodium)FDA LinkGeneric
01/2012 - 11/2003
4Small Interfering RNA (siRNA)IBA
03/2022 - 06/2012
3Proteins (Proteins, Gene)FDA Link
03/2022 - 11/2017
3Polylactic Acid-Polyglycolic Acid CopolymerIBA
03/2019 - 08/2010
2SolventsIBA
03/2019 - 11/2017
2Biological ProductsIBA
03/2019 - 01/2017
2Peptides (Polypeptides)IBA
03/2019 - 08/2002
2EmulsionsIBA
03/2019 - 11/2017
2Pharmaceutical PreparationsIBA
10/2017 - 01/2012
2Integrin-Binding SialoproteinIBA
06/2012 - 04/2010
2CollagenIBA
11/2011 - 08/2002
2TyrphostinsIBA
02/2005 - 10/2004
2tyrphostin AGL-2043IBA
02/2005 - 10/2004
2Phenobarbital (Luminal)FDA Link
10/2004 - 08/2002
1Surface Antigens (Surface Antigen)IBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1Circular DNAIBA
01/2022
1LipidsIBA
11/2019
1Apolipoproteins B (ApoB)IBA
03/2019
1ApolipoproteinsIBA
03/2019
1LDL Lipoproteins (beta Lipoproteins)IBA
03/2019
1Proteoglycans (Proteoglycan)IBA
03/2019
1Messenger RNA (mRNA)IBA
03/2019
1CytokinesIBA
08/2018
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2018
1Double-Stranded RNA (RNA, Double Stranded)IBA
11/2017
1SolutionsIBA
10/2017
1Gadolinium DTPA (Magnevist)FDA Link
10/2017
1Antineoplastic Agents (Antineoplastics)IBA
06/2012
1Paclitaxel (Taxol)FDA LinkGeneric
11/2011
1salicylhydroxamic acid (SHAM)IBA
11/2011
1Simvastatin (Zocor)FDA LinkGeneric
06/2010
1PlicamycinFDA Link
04/2009
1Dosage Forms (Dosage Form)IBA
08/2007
1AlbuminsIBA
08/2007
1GalliumIBA
02/2007
1GadoliniumIBA
02/2007
1Silicon Dioxide (Silica)FDA LinkGeneric
09/2006
1BuffersIBA
09/2006
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
10/2004
1Integrin alphaVbeta3IBA
08/2002
1Matrix Metalloproteinases (MMPs)IBA
08/2002
1Metalloproteases (Metalloproteinases)IBA
08/2002
1marimastatIBA
08/2002
1batimastat (BB 94)IBA
08/2002
1ZincIBA
08/2002
1Clodronic Acid (Clodronate)IBA
07/2002
1Cholecalciferol (Vitamin D3)FDA Link
02/2002

Therapy/Procedure

6Therapeutics
01/2022 - 01/2012
4Stents
07/2012 - 12/2003
1Quantum Dots (Quantum Dot)
11/2019
1Drug-Eluting Stents
07/2012
1Percutaneous Coronary Intervention
11/2011
1Nanospheres
09/2006
1Intravenous Administration
07/2002